According to KLAS Research, healthcare technology procurement decisions made in haste are the most common reason for buyer's remorse — and the AI agent category is producing more haste than most. Every healthtech CTO is asking the same question right now: build our own AI agents, or buy from a platform vendor?
It's the right question — and the way most teams answer it is wrong, because they treat it as a software-procurement decision when it's actually a strategy decision. This blog gives you a framework to decide. For broader context, see our pillar guide on AI Agents in Healthcare.
What Does "Build or Buy" Actually Mean Here?
"Buy" means licensing an AI agent platform — Hippocratic, Hyro, Nabla, Paratus, or one of the many vertical-specific vendors we cover in the agentic AI vendor landscape 2026. The vendor provides the runtime, the model orchestration, basic clinical guardrails, and EHR adapters. You configure prompts and deploy.
"Build" means owning the stack — model selection, memory, tools, orchestration, evaluation, observability. Frameworks like LangGraph, CrewAI, and Temporal accelerate this but the design and operation is yours.
The Default Answer Is Buy — Unless
Start from this position: buy unless you have a defensible reason to build. The agent platform market in 2026 is more mature than it was 18 months ago. For most generic healthcare workflows — patient intake, basic triage, scheduling — buying is faster, cheaper, and lower-risk.
The "unless" is what most teams underestimate. Build when:
- The workflow is your product's differentiator. If your moat is the way your agent handles prior auth for a specialty drug, you can't outsource the brain of your business.
- The workflow touches data the vendor can't see. Proprietary clinical notes, custom risk scores, data not yet mapped to FHIR.
- You have engineers who understand both healthcare and LLMs. Without that combination, you're heading toward a $250K POC.
The True Cost of "Buy"
The sticker price looks predictable. It rarely is. Real total cost of ownership in 2026 includes:
- Platform license: $50K–$300K/year for mid-market healthtech
- Per-call inference: $0.03–$0.15 per agent invocation, scaling linearly
- Integration engineering: 8–16 weeks to wire the vendor to EHR, claims, and patient data
- Compliance review: 4–8 weeks for security/privacy, BAA, IT sign-off
- Configuration and prompt tuning: ongoing, 0.5–1 FTE
- Vendor lock-in: the bigger cost. Switching after 18 months is expensive and rarely happens.
A platform marketed at "$99/user" frequently lands at $47/patient/month once production traffic hits it.
The True Cost of "Build"
Building isn't cheap either. A realistic build path includes:
- Engineering team: 3–5 engineers for 4–9 months to a production v1
- LLM infrastructure: model provider + observability + evaluation
- Tool development: every FHIR endpoint, every EHR adapter, every workflow integration
- Compliance scaffolding: HIPAA controls, audit logging, encryption, BAAs
- Clinical guardrails: harder than the LLM work. More iteration than the agent itself.
- Maintenance: agents drift. Plan for ~30% of build cost annually.
Round numbers: a serious build runs $400K–$900K to a production v1, with $150K–$300K/year to maintain.
The Hybrid Pattern Most Teams End Up With
The teams that ship — and stay shipped — almost always land on a hybrid. Buy the platform for orchestration, observability, and runtime. Build the parts that touch your differentiated workflow: custom tools, domain prompts, evaluation suites, human-in-the-loop layer.
This is the pattern frameworks like LangGraph and Temporal are designed for. You buy the foundation. You own the workflow logic. See how this connects to the strategic adoption framework for hospitals.
A Decision Framework You Can Use
Score your use case across five dimensions, 1–5 each:
- Workflow uniqueness — how custom vs. generic?
- Data sensitivity — how proprietary is the data?
- Volume — how many agent calls per month at scale?
- Strategic value — does this define your moat?
- Engineering capacity — do you have the team to build well?
Roughly: under 12 = buy. 12–17 = hybrid. Above 17 = build. Not science, but it sorts most decisions correctly.
Real-World Example
A Series B US healthtech in the chronic care space recently faced this decision. They evaluated three buy options and one build path. The build estimate was $620K to v1 with a 5-engineer team over 7 months. The buy option was $180K/year with a 12-week integration. They scored 14 on the framework above. They landed on hybrid: bought the platform for runtime, built their differentiated risk scoring and patient-matching tools on top. Eighteen months later, they have not regretted the choice. (Engagement details are illustrative — drawn from common ROI patterns we see in healthcare AI deployments.)
Common Build vs Buy Pitfalls
Three mistakes cost teams the most money and time:
- Underestimating compliance work on a "buy" decision. Procurement assumes the vendor handles HIPAA. The vendor's BAA covers their infrastructure, not your integration code. Compliance review, audit logging, role-based access on your side typically adds 4-8 weeks beyond the vendor's quoted timeline.
- Building because "it's cheaper long-term." The math only works if engineering capacity is free. For most healthtech teams, the opportunity cost of pulling 3-5 engineers off product features for 6-9 months exceeds the platform fee. Run the calculation with realistic opportunity cost, not just direct cost.
- Locking in too early. Teams sign a 3-year enterprise contract for an agent platform in month 2 of evaluation, before understanding how the workflow actually behaves in production. Start with month-to-month or a pilot. Convert to enterprise only after you've shipped to real users.
The framework in this blog isn't a one-time decision. Re-score every 6 months as your workflow matures and your engineering capacity changes. The "buy" that was right at seed stage often becomes the "build" that's right at Series B — and vice versa.
Key Takeaways
- Default is buy. Build only when the workflow is your moat, the data is proprietary, or you have the team.
- Real buy cost is 2–3x the sticker price after integration, compliance, and lock-in.
- Real build cost is $400K–$900K to v1 plus 30% of build cost annually to maintain.
- The hybrid pattern (buy platform, build differentiation) is what most production teams converge on.
- Score your use case on uniqueness, data sensitivity, volume, strategic value, and engineering capacity before signing anything.
Call to Action
This blog is one piece of a larger picture. For the full overview, read the pillar guide: What Are AI Agents in Healthcare and How Are They Transforming Care Delivery.
Want to build or evaluate an AI agent for your healthcare product? Get in touch with Nirmitee — we ship FHIR-native, HIPAA-compliant AI agents for US healthtech teams and global hospitals.
